Great Valley Advisor Group, Inc. Exact Sciences Corp Transaction History

Great Valley Advisor Group, Inc.

$4.07 Billion
Q4 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 7,227 shares of EXAS stock, worth $345,595. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,227

Previous 8,534 15.32%

Holding current value

$345,595

Previous $581,000 30.12%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 24, 2025	SELL	$49.33 - $71.97 $64,474 - $94,064	-1,307 Reduced 15.32%	7,227 $406,000
Q3 2024 Nov 12, 2024	SELL	$42.43 - $70.83 $6,661 - $11,120	-157 Reduced 1.81%	8,534 $581,000
Q2 2024 Jul 16, 2024	BUY	$41.33 - $74.26 $5,455 - $9,802	132 Added 1.54%	8,691 $367,000
Q1 2024 May 03, 2024	BUY	$56.27 - $73.77 $82,998 - $108,810	1,475 Added 20.82%	8,559 $591,000
Q4 2023 Feb 05, 2024	BUY	$59.06 - $75.72 $236 - $302	4 Added 0.06%	7,084 $524,000
Q3 2023 Nov 06, 2023	SELL	$65.94 - $99.04 $65 - $99	-1 Reduced 0.01%	7,080 $482,000
Q2 2023 Aug 10, 2023	SELL	$62.68 - $95.05 $35,852 - $54,368	-572 Reduced 7.47%	7,081 $664,000
Q1 2023 May 02, 2023	SELL	$47.19 - $70.77 $11,797 - $17,692	-250 Reduced 3.16%	7,653 $518,000
Q4 2022 Jan 31, 2023	SELL	$30.35 - $53.15 $11,684 - $20,462	-385 Reduced 4.65%	7,903 $391,000
Q3 2022 Oct 21, 2022	SELL	$31.97 - $49.37 $31 - $49	-1 Reduced 0.01%	8,288 $269,000
Q2 2022 Jul 19, 2022	SELL	$35.61 - $76.23 $11,288 - $24,164	-317 Reduced 3.68%	8,289 $327,000
Q1 2022 Apr 20, 2022	SELL	$57.56 - $82.54 $32,981 - $47,295	-573 Reduced 6.24%	8,606 $602,000
Q4 2021 Feb 10, 2022	SELL	$72.5 - $100.68 $1.57 Million - $2.17 Million	-21,590 Reduced 70.17%	9,179 $714,000
Q3 2021 Oct 14, 2021	BUY	$90.24 - $124.05 $739,968 - $1.02 Million	8,200 Added 36.33%	30,769 $2.94 Million
Q2 2021 Jul 27, 2021	BUY	$93.66 - $139.27 $74,178 - $110,301	792 Added 3.64%	22,569 $2.81 Million
Q1 2021 Apr 20, 2021	BUY	$116.57 - $155.01 $214,139 - $284,753	1,837 Added 9.21%	21,777 $2.87 Million
Q4 2020 Jan 29, 2021	SELL	$99.61 - $142.12 $97,518 - $139,135	-979 Reduced 4.68%	19,940 $2.64 Million
Q3 2020 Oct 21, 2020	SELL	$72.92 - $102.01 $167,788 - $234,725	-2,301 Reduced 9.91%	20,919 $2.13 Million
Q2 2020 Jul 31, 2020	SELL	$55.75 - $92.75 $128,671 - $214,067	-2,308 Reduced 9.04%	23,220 $2.02 Million
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $121,924 - $335,983	3,217 Added 14.42%	25,528 $1.48 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $442,584 - $568,418	5,699 Added 34.31%	22,311 $2.06 Million
Q3 2019 Oct 25, 2019	BUY	$90.37 - $122.49 $411,544 - $557,819	4,554 Added 37.77%	16,612 $1.5 Million
Q2 2019 Jul 30, 2019	BUY	$89.51 - $118.04 $262,174 - $345,739	2,929 Added 32.08%	12,058 $1.42 Million
Q1 2019 Apr 26, 2019	BUY	$61.98 - $96.5 $260,501 - $405,589	4,203 Added 85.32%	9,129 $791,000
Q4 2018 Apr 11, 2019	BUY	$56.04 - $82.66 $276,053 - $407,183	4,926 New	4,926 $311,000

Others Institutions Holding EXAS

# of Institutions

672

Shares Held

164M

Call Options Held

4.25M

Put Options Held

1.89M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.46B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Exact Sciences Corp Transaction History